![]() |
|
|
Subunits Important for Specificity of Receptor-G Protein Interaction
Laboratory for Molecular Pharmacology, the Panum Institute, University of Copenhagen, Copenhagen, Denmark (A.H., M.M.R.); 7TM Pharma A/S, Hørsholm, Denmark (R.J., T.M.F., E.K.); Molecular Pharmacology Group, Division of Biochemistry and Molecular Biology, Institute of Biomedical and Life Sciences, University of Glasgow, Glasgow, Scotland, United Kingdom (R.J.W., G.M.)
Several domains of G protein
subunits are implicated in the control of receptor-G protein coupling specificity. Among these are the extreme N-and C-termini, the
4/
6-loops, and the loop linking the N-terminal
-helix to the
1-strand of the ras-like domain. In this study, we illustrate that single-point mutations of a highly conserved glycine residue within the linker I region of the G
q subunit confers upon the mutant G
q the ability to be activated by G
i- and G
s -coupled receptors, as evidenced by guanosine 5'-O-(3-[35S]thio)triphosphate binding and inositol phosphate turnover assays. The mutations did not affect expression of G
q proteins nor their ability to stimulate phospholipase C
. It is noteworthy that both mutant and wild-type G
q proteins are indistinguishable in their ability to reconstitute a functional Gq-PLC
-calcium signaling pathway when cotransfected with the G
q-coupled neurokinin 1 or muscarinic M3 receptor into mouse embryonic fibroblasts derived from G
q/11 knockout mice. On a three-dimensional model of the receptor-G protein complex, the highly conserved linker I region connecting the helical and the GTPase domain of the G
protein is inaccessible to the intracellular surface of the receptors. Our data indicate that receptor-G protein coupling specificity is not exclusively governed by direct receptor-G protein interaction and that it even bypasses the requirement of the extreme C terminus of G
, a well accepted receptor recognition domain, suggesting a novel allosteric mechanism for G protein-coupled receptor-G protein selectivity.
Address correspondence to: Evi Kostenis, 7TM Pharma A/S, Fremtidsvej 3, 2970 Hørsholm, Denmark. E-mail: ek{at}7tm.com
This article has been cited by other articles:
![]() |
T. Krietsch, M. S. Fernandes, J. Kero, R. Losel, M. Heyens, E. W.-F. Lam, I. Huhtaniemi, J. J. Brosens, and B. Gellersen Human Homologs of the Putative G Protein-Coupled Membrane Progestin Receptors (mPR{alpha}, {beta}, and {gamma}) Localize to the Endoplasmic Reticulum and Are Not Activated by Progesterone Mol. Endocrinol., December 1, 2006; 20(12): 3146 - 3164. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Kostenis, G. Milligan, A. Christopoulos, C. F. Sanchez-Ferrer, S. Heringer-Walther, P. M. Sexton, F. Gembardt, E. Kellett, L. Martini, P. Vanderheyden, et al. G-Protein-Coupled Receptor Mas Is a Physiological Antagonist of the Angiotensin II Type 1 Receptor Circulation, April 12, 2005; 111(14): 1806 - 1813. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Kostenis, L. Martini, J. Ellis, M. Waldhoer, A. Heydorn, M. M. Rosenkilde, P. K. Norregaard, R. Jorgensen, J. L. Whistler, and G. Milligan A Highly Conserved Glycine within Linker I and the Extreme C Terminus of G Protein {alpha} Subunits Interact Cooperatively in Switching G Protein-Coupled Receptor-to-Effector Specificity J. Pharmacol. Exp. Ther., April 1, 2005; 313(1): 78 - 87. [Abstract] [Full Text] [PDF] |
||||